INDEXED STUDIES
KPV — Indexed Studies
27 most recent studies indexed by PSI from PubMed and clinical databases
Showing 27 of 27 studies
Self-Cross-Linked Hydrogel of Cysteamine-Grafted γ-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats.
Sun J, Xue P, Liu J et al.
Novel anti-inflammatory and chondroprotective effects of the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride and human melanocortin MC3 receptor agonist PG-990 on lipopolysaccharide activated chondrocytes.
Can VC, Locke IC, Kaneva MK et al.
Are melanocortin peptides future therapeutics for cutaneous wound healing?
Böhm M, Luger T
Structural modification of the tripeptide KPV by reductive "glycoalkylation" of the lysine residue.
Songok AC, Panta P, Doerrler WT et al.
Peptide Receptor-Targeted Fluorescent Probe: Visualization and Discrimination between Chronic and Acute Ulcerative Colitis.
Zeng M, Shao A, Li H et al.
Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Xiao B, Xu Z, Viennois E et al.
Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists.
Land SC
Modulation of basophil activity: a novel function of the neuropeptide α-melanocyte-stimulating hormone.
Böhm M, Apel M, Sugawara K et al.
Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.
Kannengiesser K, Maaser C, Heidemann J et al.
alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs.
Luger TA, Brzoska T
Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide.
Bonfiglio V, Camillieri G, Avitabile T et al.
Inhibitory effects of the peptide (CKPV)2 on endotoxin-induced host reactions.
Gatti S, Carlin A, Sordi A et al.
Immobilized alpha-melanocyte stimulating hormone 10-13 (GKPV) inhibits tumor necrosis factor-alpha stimulated NF-kappaB activity.
Kelly JM, Moir AJ, Carlson K et al.
Three-dimensional structure of the alpha-MSH-derived candidacidal peptide [Ac-CKPV]2.
Catania A, Grieco P, Randazzo A et al.
alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells.
Elliott RJ, Szabo M, Wagner MJ et al.
Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.
Getting SJ, Schiöth HB, Perretti M
Downregulation of glucocorticoid receptors of liver cytosols and the role of the inflammatory cytokines in pathological stress in scalded rats.
Liu DH, Su YP, Zhang W et al.
[Changes in aldosterone binding activity of kidney cytosol after stress in rats and the regulation].
Liu DH, Su YP, Zhang W et al.
Alpha-melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes.
Barcellini W, Colombo G, La Maestra L et al.
Antimicrobial effects of alpha-MSH peptides.
Cutuli M, Cristiani S, Lipton JM et al.
Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease.
Rodrigues JM, Ferreira Leal AP, Buccini DF et al.
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials.
Gravina AG, Pellegrino R, Durante T et al.
Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore.
Brzoska T, Böhm M, Lügering A et al.
Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases.
Brzoska T, Luger TA, Maaser C et al.
New insights into the functions of alpha-MSH and related peptides in the immune system.
Luger TA, Scholzen TE, Brzoska T et al.
The neuropeptide alpha-MSH in host defense.
Catania A, Cutuli M, Garofalo L et al.
The neuroimmunomodulatory peptide alpha-MSH.
Ichiyama T, Sato S, Okada K et al.
Considering peptide therapy?
Find a vetted physician in our directory who specializes in evidence-based peptide protocols.
Find a Physician